US FDA approves bi-weekly teclistamab dosing in relapsed/refractory myelomaAccess, MPE, MyelomaFebruary 22, 2024
Sign up for the MPE webinar “AL amyloidosis treatment updates and patient experiences on new therapies”AL amyloidosis, MPEMarch 27, 2024
EMA CHMP confirms recommendation for non-renewal of Blenrep marketing authorisationAccess, MPEDecember 15, 2023
MPE to present at European Society for Medical Oncology (ESMO) Annual Congress 2023Conferences, MPEOctober 17, 2023
Watch the recording of the EHA 2023 highlights webinarAL amyloidosis, MPE, Myeloma, VideosJuly 10, 2023
Watch the webinar on ASH 2020 myeloma and AL amyloidosis highlightsAL amyloidosis, Conferences, MPE, Myeloma, VideosDecember 18, 2020
